Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Longboard Pharmaceuticals Inc increased its cash reserves by 33.00%, or 3.56m. Cash Flow from Financing totalled 30.19m or -- of revenues. In addition the company used 50.87m for operations while cash from investing totalled 24.23m.
Cash flow per share | -2.13 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.58 |
---|---|
Tangible book value per share | 7.58 |
More ▼
Balance sheet in USDView more
Current ratio | 20.95 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼